Nasdaq
$9.25▲ 0.33%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $54.0MShares out 5.8M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
6- 10.9After-hours26.10.10 06:0140-8F-2/AOther#●●●#●●●
DAXOR CORP
Daxor Corporation has filed an application to deregister as an investment company under the Investment Company Act of 1940. As of December 31, 2025, the company holds zero investment securities and will continue to operate exclusively as a radiopharmaceutical and medical device manufacturer.…more
$9.25+0.33%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 9.24After-hours26.09.25 06:17N-CEN/AOther
DAXOR CORP
Daxor Corporation has completed its independent audit of the financial statements for the fiscal year ended December 31, 2025. The auditor, Bush & Associates, issued an unqualified opinion stating that the financial statements fairly present the company's financial position and results of operations in accordance with U.S. GAAP.…more
$9.25+0.33%vs prev closeView filingShare - 9.1Regular26.09.02 04:264Ownership
DAXOR CORP
Daxor Corp insider John Jefferies filed an SEC Form 4 on September 1, 2026, reporting a change in beneficial ownership of company securities as of August 28, 2026. This filing serves as a standard disclosure regarding the insider's equity position.…more
$9.25+0.33%vs prev closeView filingShare
5 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.14Pre-market26.10.14 21:08#●●●#●●●
Daxor Validates BVA Technology for Heart Failure Care at HFSA Meeting
Daxor presented new clinical data at the HFSA Annual Scientific Meeting demonstrating that its BVA technology improves diagnostic precision and treatment outcomes for high-acuity heart failure patients. The studies highlight the system's ability to identify complex fluid and blood volume abnormalities that standard examinations often miss.…more
$9.25+0.33%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 9.8After-hours26.09.09 06:40
●●●●●●●● ●●●●● ●●●●●●
Daxor Corporation announced its participation in the 10th Annual Lake Street Best Ideas Growth Conference. Management will engage in one-on-one and small group meetings with investors during the event.…more
$9.25+0.33%vs prev close - 9.1Pre-market26.09.01 21:00
●●●●●●●● ●●●●● ●●●●●●
Daxor is focusing on scaling its commercial team and manufacturing capacity to drive growth for its blood volume measurement technology. The company expects increased demand for its next-generation analyzer to support broader market adoption in the coming quarters.…more
$9.25+0.33%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report